Medical research in the UK has a long and distinguished history and the recent changes to the NHS in the Health & Social Care Act seek to protect and build on this. Most life science companies will be both affected by and be able to benefit from the patient data access capability that will give an increasingly accurate picture of the impact on health outcomes of various treatment regimes. Read more. (Source: eyeforpharma, 7/5/13).
You are here: / Real World Data Governance-“Caldicott2”